Acro Biomedical (ACBM) Cash from Operations Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | -33.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -33.91% |
| Sep 30, 2025 | -0.71% |
| Jun 30, 2025 | 35.22% |
| Mar 31, 2025 | -27.77% |
| Dec 31, 2024 | 44.20% |
| Sep 30, 2024 | 53.87% |
| Jun 30, 2024 | -26.30% |
| Mar 31, 2024 | -17.27% |
| Sep 30, 2023 | 26.15% |
| Jun 30, 2023 | 26.65% |
| Mar 31, 2023 | 40.19% |
| Dec 31, 2022 | -32.05% |
| Sep 30, 2022 | 17.43% |
| Jun 30, 2022 | -35.98% |
| Mar 31, 2022 | 91.37% |
| Dec 31, 2021 | -32.90% |
| Sep 30, 2021 | -149.28% |
| Jun 30, 2021 | 41.69% |
| Mar 31, 2021 | -26.42% |
| Sep 30, 2020 | 46.26% |
| Jun 30, 2020 | -59.95% |
| Mar 31, 2020 | 4.08% |
| Dec 31, 2019 | 528.25% |
| Sep 30, 2019 | -114.36% |
| Jun 30, 2019 | -190.64% |
| Mar 31, 2019 | -85.76% |
| Dec 31, 2018 | 158.81% |
| Sep 30, 2018 | -40.02% |